Cytomegalovirus in Ulcerative Colitis: An Unwanted “Guest”-Reference-Cited by-同舟云学术

Cytomegalovirus in Ulcerative Colitis: An Unwanted “Guest”

Published:2024-08-02 Issue:8 Volume:13 Page:650
ISSN:2076-0817
Container-title:Pathogens
language:en
Short-container-title:Pathogens

Author:

Onisor Danusia¹²^ORCID,Brusnic Olga¹²,Mocan Simona³,Stoian Mircea⁴^ORCID,Avram Calin⁵^ORCID,Boicean Adrian⁶^ORCID,Dobru Daniela¹²^ORCID

Affiliation:

1. Department of Internal Medicine VII, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540139 Targu Mures, Romania

2. Gastroenterology Department, Mureș County Clinical Hospital, 540103 Targu Mures, Romania

3. Pathology Department, Emergency County Hospital, 540136 Targu Mures, Romania

4. Department of Anesthesiology and Intensive Care, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania

5. Department of Medical Informatics and Biostatistics, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540139 Targu Mures, Romania

6. Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania

Abstract

The role of cytomegalovirus (CMV) in the flare-up of ulcerative colitis (UC) is not clearly understood. CMV can cause similar symptoms in different clinical contexts, which may be attributed to the natural evolution of the viral infection, the patient’s immune status, or its association with inflammatory bowel disease (IBD). This study aims to delineate the diverse manifestations of CMV-related lesions from clinical, endoscopic, and histopathological perspectives, alongside a brief narrative review of the literature. In managing IBD patients, it is crucial to be vigilant for signs of CMV reactivation, especially before the initiation of more intensive therapies.

Funder

University of Medicine, Pharmacy, Science and Technology “George Emil Palade”, Târgu Mureș

Publisher

MDPI AG

Link

https://www.mdpi.com/2076-0817/13/8/650/pdf

Reference56 articles.

1. Cytomegalovirus-induced immunopathology and its clinical consequences;Varani;Herpesviridae,2011

2. Diagnosis and treatment of ulcerative colitis with cytomegalovirus infection: Importance of controlling mucosal inflammation to prevent cytomegalovirus reactivation;Nakase;Intest. Res.,2014

3. Fisher, M.A., and Lloyd, M.L. (2021). A Review of Murine Cytomegalovirus as a Model for Human Cytomegalovirus Disease—Do Mice Lie?. Int. J. Mol. Sci., 22.

4. Rat Cytomegalovirus Major Immediate-Early Enhancer Switching Results in Altered Growth Characteristics;Sandford;J. Virol.,2001

5. Complement-Fixing Antibodies against Cytomegalovirus in Different Parts of the World;Krech;Bull. World Health Organ.,1973